Inherited thrombophilias and pre-eclampsia in Brazilian women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 134, Issue 1, 2007, Pages 20-23

  Dusse, Luci Maria SantAna ^a   Carvalho, Maria das Graças ^a   Bragança, William Fialho ^a   Paiva, Sabrina Guimarães ^a   Godoi, Lara Carvalho ^a   Guimarães, Daniela Amorim Melgaço ^a   Fernandes, Ana Paula ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Brazilian women; C677T; G1691A; G20210A; Pre eclampsia

Indexed keywords

ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INHERITANCE; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOPHILIA;

EID: 34548230482     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2006.09.006     Document Type: Article

References (35)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obst Gynecol 2000;183:S1-22.
2. Sibai B.M., Caritis S.N., Thom E., et al. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Prevention of pre-eclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med 329 (1993) 1213-1218
3. Gilabert J., Estellés A., España F., Grancha S., and Aznar J. Modifications de la hemostasia en obstetricia. Rev Iberoamer Tromb Hemostasia 8 (1995) 102-112
4. Estelles A., Gilabert J., Grancha S., et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe pre-eclampsia. Thromb Haemost 79 (1998) 500-508
5. Kobayashi T., Tokunaga N., Sugimura M., Kanayama N., and Terao T. Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe pre-eclampsia. Semin Thromb Hemost 27 2 (2001) 137-141
6. Bertina R.M., and Factor V. Leiden and other coagulation factor mutations affecting thrombotic risk. Clin Chem 43 (1997) 1678-1683
7. Poort S.R., Rosendal F.R., Reistma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
8. D'angelo A., and Selhub J. Homocysteine and thrombotic disease. Blood 90 (1997) 1-11
9. Agorastos T., Karavida A., Lambropoulos A., et al. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome. J Matern Fetal Neonatal Med 12 4 (2002) 267-273
10. Kupferminc M.J., Fait G., Many A., Gordon D., Eldor A., and Lessing J.B. Severe pre-eclampsia and high frequency on genetic thrombophilic mutations. Obstet Ginecol 96 (2000) 45-49
11. De Groot C.J.M., loemenkamp K.W.M., Duvekot E.I., et al. Pre-eclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Ginecol 181 40 (1999) 975-980
12. D'aniello G., Florio P., Sabatini I., et al. The search for thrombophilic gene mutations in women with gestational hypertension does not help in predicting poor pregnancy outcome. J Hypertens 21 10 (2003) 1915-1920
13. Fabbro D., D'elia A.V., Spizzo R., et al. Association between plasminogen activator inhibitor 1 gene polymorphisms and pre-eclampsia. Gynecol Obstet Invest 56 1 (2003) 17-22
14. De Maat M.P.M., Jansen M.W.J.C., Hille E.T.M., et al. Pre-eclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost 2 (2004) 1588-1593
15. Parra F.C., Amado R.C., Lambertucci J.R., Rocha J., Antunes C.M., and Pena S.D.J. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci 100 (2003) 177-182
16. Frosst P., Blom H.J., Milos R., et al. A candidate risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Gen 10 (1995) 111-113
17. Huber S., McMmaster K.J., and Voelkerding K.V. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of Factor V Leiden and prothrombin G20210A. J Mol Diagn 2 (2000) 153-157
18. Dean AG, Dean JA. Coulombier, D. Epi Info, Version 6.04: a word processing database and statistics program for epidemiology on microcomputers. Atlanta: Centre of Disease Control and Prevention, 1997.
19. Gerhardt A., Goecke T.W., Beckmann M.W., et al. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe pre-eclampsia. J Thromb Haemost 3 (2004) 686-691
20. Dudding T.E., and Attia J. The association between adverse pregnancy outcomes and maternal Factor V Leiden genotype: a meta-analysis. Thromb Haemost 91 4 (2004) 700-711
21. Lin J., and August P. Genetic thrombophilias and pre-eclampsia: a meta-analysis. Obstet Gynecol 105 1 (2005) 182-192
22. Mello G., Parretti E., Marozio L., et al. Thrombophilia is significantly associated with severe pre-eclampsia: results of a large-scale, case-controlled study. Hypertension 46 6 (2005) 1270-1274
23. Prasmusinto D., Skrablin S., Fimmers R., and Van Der Ven K. Ethnic differences in the association of Factor V Leiden mutation and the C677T methylenetetrahydrofolate reductase gene polymorphism with pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 112 2 (2004) 162-169
24. Arruda V.R., Annichino-Bizzacchi J.M., Costa F.F., and ReistmaF P.H. Factor V Leiden (FVQ 506) is a common in a Brazilian population. A J Hematol 49 (1995) 242-243
25. Arruda V.R., Annichino-Bizzacchi J.M., Gonçalves M.S., and Costa F.F. Prevalence of the prothrombin gene variant (G20210A) in venous thrombosis and arterial disease. Throm Haemost 78 6 (1997) 1430-1433
26. Arruda V.R., Siqueira L.H., Gonçalves M.S., et al. Prevalence of mutation C677T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet 78 (1998) 332-335
27. de Paula Sabino A., Ribeiro D.D., Carvalho M.G., Cardoso J.E., Dusse L.M., and Fernandes A.P. Factor V Leiden and increased risk for arterial thrombotic disease in young Brazilian patients. Blood Coagul Fibrinol 17 4 (2006) 271-275
28. Clarizia A.D., Bastos-Rodrigues L., Pena H.B., et al. Relationship of the methylenetetrahydrofolate reductase C677T polymorphism with microsatellite instability and promoter hypermethylation in sporadic colorectal cancer. Genet Mol Res 5 2 (2006) 315-322
29. Carod-Artal F.J., Nunes S.V., Portugal D., Silva T.V., and Vargas A.P. Ischemic stroke subtypes and thrombophilia in young and elderly Brazilian patients admitted to a rehabilitation hospital. Stroke 36 9 (2005) 2012-2014
30. Zanrosso C.W., Hatagima A., Emereciano M., et al. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leukemia Res 30 (2006) 477-481
31. Pereira AC, Lourenço DM, Maffei FH, et al. A transcobalamin gene polymorphism and the risk of venous thrombosis. The BRATOS (Brazilian Thrombosis Study). Thrombosis Research, 2006.
32. Pinto R.B., Silveira R.T., Bandinelli E., and Röhsig L. Portal vein thrombosis in children and adolescents: the low prevalence of hereditary thrombophilic disorders. J Ped Surg 39 9 (2004) 1356-1361
33. Jaques P.F., Bostom A.G., Willians R.R., et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
34. Cotter A.M., Molloy A.M., Scott J.M., and Daly S.F. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of non-severe pre-eclampsia. Am J Obstet Gynecol 189 2 (2003) 391-394
35. Greer I.A. Thrombophilia: implications for pregnancy outcome. Thromb Res 109 2-3 (2003) 73-81